T1	Intervention 0 71	Mexiletine for HIV-infected patients with painful peripheral neuropathy
T2	Intervention 417 446	mexiletine in HIV-related PPN
T3	Intervention 499 651	receive mexiletine (maximum dose, 600 mg/day) or placebo for 6 weeks, followed by the alternative intervention for 6 weeks after a 1-week washout period
T4	Intervention 1164 1184	receiving mexiletine
T5	Intervention 1217 1224	placebo
